Market Research Life Sciences Market Research Pharmaceuticals Market Research Clinical Nutrition Market Research

Specialty Generics Market Forecasts to 2028 – Global Analysis By Type (Oral Drugs, Injectables, Topical, Parenteral and Other Types), By Application (Hepatitis C, Multiple Sclerosis, Inflammatory Conditions, Oncology, Cardiovascular, Infectious Diseases,

Best Price Guarantee Length Publisher Published Date SKU
from $4,150 175 Pages Stratistics Market Research Consulting June, 2023 SMR18014642
Best Price Guarantee
Price from $4,150
Length 175 Pages
Publisher Stratistics Market Research Consulting
Published Date June, 2023
SKU SMR18014642

Specialty Generics Market Forecasts to 2028 – Global Analysis By Type (Oral Drugs, Injectables, Topical, Parenteral and Other Types), By Application (Hepatitis C, Multiple Sclerosis, Inflammatory Conditions, Oncology, Cardiovascular, Infectious Diseases, Autoimmune Diseases and Other Applications), By End User and By Geography


According to Stratistics MRC, the Global Specialty Generics Market is accounted for $69.9 billion in 2022 and is expected to reach $176.6 billion by 2028 growing at a CAGR of 16.7% during the forecast period. Once a specialty drug's patent expires, generic versions of it are referred to as specialty generics. Complex, chronic diseases like cancer, multiple sclerosis, and rheumatoid arthritis may all be treated with these medications. Specialty generics are less expensive than branded equivalents because they have lower development and marketing expenses.

According to the World Health Organization (WHO), the geriatric population increased from 1 billion in 2020 to 1.4 billion in 2021. By 2030, one in six people in the world will be aged 60 years and above.

Market Dynamics

Driver

Increasing cases of chronic diseases to fuel the demand for specialty generics

Globally, there have been more incidences of numerous life-threatening illnesses, such as cancer, multiple sclerosis (MS), and HIV, and it is projected that this will lead to a rise in the use of specialty medications. For instance, according to data from the Global RA Network published in 2021, there are already 350 million individuals living with arthritis worldwide, and this number is likely to rise over the next few years. Additionally, according to data released by Globocan in 2020, 9.7% of the world's population, or Europe, represented 19.6% of cancer deaths and 22.8% of all cancer diagnoses.

Restraint

High capital cost and complex manufacturing requirements

Due to the sophisticated manufacturing needs, greater capital expenditures, and generally lower quantities as a result of a smaller patient population, specialist generics have a more competitive market than regular generics. Specialty generic drugs typically require prior authorization to be ordered, specific handling, administration, and monitoring. These elements are further hindering the market growth.

Opportunity

Patent expiration of specialty drugs

As payers and patients seek methods to save healthcare costs, demand for specialty generics is expanding globally. To ensure that patients who require advanced generic medicines have access to them, a number of well-known market participants are concentrating on the release of generic versions of medications. For instance, Teva Pharmaceuticals, Inc. introduced Revlimid (capsules containing lenalidomide) in the United States in March 2022. In order to treat multiple myeloma in adults, the first generic version of Revlimid was introduced in strengths of 5mg, 10mg, 15mg, and 25mg.

Threat

Lack of awareness and low profitability

High complexity of specialist generic medicines, low profitability, and brand recognition and loyalty are important issues that, to some extent, restrict market expansion. People are bearing the burden of rising healthcare costs as a result of the general public's lack of knowledge about the availability of generic medications at pharmacies, which forces them to spend more on branded medications. During the projected period, these factors are anticipated to limit the market's growth.

Covid-19 Impact

The COVID-19 pandemic's impact on the market caused the industry to grow more slowly as a result of the suspension of various research trials and studies following the big virus epidemic, lockdown limitations in industrial facilities, and a lack of qualified employees. Additionally, a number of pharmaceutical firms witnessed a reduction in their net revenues in 2020 as a result of COVID-19. Instead, due to widespread vaccinations, a relaxation of lockdown restrictions, and a rise in the need for specialist medications to treat chronic ailments, the market recovered in 2021 as compared to 2020.

The oral drugs segment is expected to be the largest during the forecast period

Oral Drugs segment is expected to have dominant share throughout the projection period. The quickest, simplest, and safest method of administration for generic medications is oral. As a result of their ease of use for frequent and sustained usage, self-administration, and lack of pain, they are the most often used and manufactured form of pharmaceuticals. The product launches credited with the segment's supremacy in the market attract the attention of market participants. For instance, Par Pharmaceutical, Inc. (Par), a subsidiary of Endo International plc, was granted FDA approval in January 2022 to market the country's first generic version of Merz's CUVPOSA (glycopyrrolate).

The oncology segment is expected to have the highest CAGR during the forecast period

Oncology segment accounted for lucrative growth over the forecasted period, because there are more generic cancer medications available and there is a greater demand for cancer treatment solutions that are effective. For instance, Sun Pharmaceutical Industries Ltd. introduced the generic version of Palbociclib, a breast cancer treatment from Pfizer, in India in January 2023. These factors are anticipated to boost segment growth due to the adoption of a Western lifestyle, excessive alcohol and tobacco use, poor dietary choices, and physical inactivity.

Region with largest share

North America is expected to have the largest share during the domination period, due to the existence of regulatory policies that favor the approval of innovative products. The American FDA has launched a number of initiatives aimed at streamlining the entire approval procedure. Thus, the Hatch-Waxman Act's Generic Drug User Free Amendments (GDUFA) were introduced by the U.S. FDA to accelerate the distribution of affordable, safe, and effective generic medications to the general population. Therefore, the major producers continually work to commercialize specialty generic medicines on the market.

Region with highest CAGR

Asia Pacific region is anticipated to witness rapid growth throughout the extrapolated period, due to the expansion of biopharmaceutical companies in China and India, which is anticipated to drive the market in this region. Additionally, the region is expanding as a result of the favorable regulatory regulations governing the approval and introduction of new generic drugs there. However, pharmaceutical companies are continually working to promote specialty medications in the region. The market in the Asia-Pacific area has grown as a result of these factors.

Key players in the market

Some of the key players in Specialty Generics market include Akorn, Inc., Amneal Pharmaceuticals LLC, Bausch Health Companies Inc, Dr. Reddy’s Laboratories, Ltd., Endo International plc., Endo Pharmaceuticals Inc., Hikma Pharmaceuticals PLC, Lupin, Mallinckrodt, Mylan N.V., Novartis AG, Pfizer, Inc., Sandoz International GmbH, Sun Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc. and Viatris Inc..

Key Developments

In June 2022, Amneal Pharmaceuticals Inc., launched LYVISPAH (baclofen) a specialty product approved by U.S. FDA for the indication of multiple sclerosis and other spinal cord disorders.

In March 2022, Viatris Inc. announced receipt of the first FDA approval for a generic version of Symbicort Inhalation Aerosol, Breyna (Budesonide and Formoterol Fumarate Dihydrate Inhalation Aerosol), in partnership with Kindeva Drug Delivery L.P. for the treatment of chronic obstructive pulmonary disease (COPD).

In January 2022, Lupin Limited partnered with the Chinese Shenzhen Foncoo Pharmaceutical Co., Ltd. The partnership aimed to sell complex generics and specialty medicines to China.

Types Covered
• Oral Drugs
• Injectables
• Topical
• Parenteral
• Other Types

Applications Covered
• Hepatitis C
• Multiple Sclerosis
• Inflammatory Conditions
• Oncology
• Cardiovascular
• Infectious Diseases
• Autoimmune Diseases
• Other Applications

End Users Covered
• Hospital Pharmacy
• Retail Pharmacy
• Specialty Pharmacy
• Online Pharmacies
• Other End Users

Regions Covered
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities,Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements


1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Specialty Generics Market, By Type
5.1 Introduction
5.2 Oral Drugs
5.3 Injectables
5.4 Topical
5.5 Parenteral
5.6 Other Types
6 Global Specialty Generics Market, By Application
6.1 Introduction
6.2 Hepatitis C
6.3 Multiple Sclerosis
6.4 Inflammatory Conditions
6.5 Oncology
6.6 Cardiovascular
6.7 Infectious Diseases
6.8 Autoimmune Diseases
6.9 Other Applications
7 Global Specialty Generics Market, By End User
7.1 Introduction
7.2 Hospital Pharmacy
7.3 Retail Pharmacy
7.4 Specialty Pharmacy
7.5 Online Pharmacies
7.6 Other End Users
8 Global Specialty Generics Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Akorn, Inc.
10.2 Amneal Pharmaceuticals LLC
10.3 Bausch Health Companies Inc
10.4 Dr. Reddy’s Laboratories, Ltd.
10.5 Endo International plc.
10.6 Endo Pharmaceuticals Inc.
10.7 Hikma Pharmaceuticals PLC
10.8 Lupin
10.9 Mallinckrodt
10.10 Mylan N.V.
10.11 Novartis AG
10.12 Pfizer, Inc.
10.13 Sandoz International GmbH
10.14 Sun Pharmaceutical Industries, Ltd.
10.15 Teva Pharmaceuticals USA, Inc.
10.16 Viatris Inc.
List of Tables
Table 1 Global Specialty Generics Market Outlook, By Region (2020-2028) ($MN)
Table 2 Global Specialty Generics Market Outlook, By Type (2020-2028) ($MN)
Table 3 Global Specialty Generics Market Outlook, By Oral Drugs (2020-2028) ($MN)
Table 4 Global Specialty Generics Market Outlook, By Injectables (2020-2028) ($MN)
Table 5 Global Specialty Generics Market Outlook, By Topical (2020-2028) ($MN)
Table 6 Global Specialty Generics Market Outlook, By Parenteral (2020-2028) ($MN)
Table 7 Global Specialty Generics Market Outlook, By Other Types (2020-2028) ($MN)
Table 8 Global Specialty Generics Market Outlook, By Application (2020-2028) ($MN)
Table 9 Global Specialty Generics Market Outlook, By Hepatitis C (2020-2028) ($MN)
Table 10 Global Specialty Generics Market Outlook, By Multiple Sclerosis (2020-2028) ($MN)
Table 11 Global Specialty Generics Market Outlook, By Inflammatory Conditions (2020-2028) ($MN)
Table 12 Global Specialty Generics Market Outlook, By Oncology (2020-2028) ($MN)
Table 13 Global Specialty Generics Market Outlook, By Cardiovascular (2020-2028) ($MN)
Table 14 Global Specialty Generics Market Outlook, By Infectious Diseases (2020-2028) ($MN)
Table 15 Global Specialty Generics Market Outlook, By Autoimmune Diseases (2020-2028) ($MN)
Table 16 Global Specialty Generics Market Outlook, By Other Applications (2020-2028) ($MN)
Table 17 Global Specialty Generics Market Outlook, By End User (2020-2028) ($MN)
Table 18 Global Specialty Generics Market Outlook, By Hospital Pharmacy (2020-2028) ($MN)
Table 19 Global Specialty Generics Market Outlook, By Retail Pharmacy (2020-2028) ($MN)
Table 20 Global Specialty Generics Market Outlook, By Specialty Pharmacy (2020-2028) ($MN)
Table 21 Global Specialty Generics Market Outlook, By Online Pharmacies (2020-2028) ($MN)
Table 22 Global Specialty Generics Market Outlook, By Other End Users (2020-2028) ($MN)
Table 23 North America Specialty Generics Market Outlook, By Country (2020-2028) ($MN)
Table 24 North America Specialty Generics Market Outlook, By Type (2020-2028) ($MN)
Table 25 North America Specialty Generics Market Outlook, By Oral Drugs (2020-2028) ($MN)
Table 26 North America Specialty Generics Market Outlook, By Injectables (2020-2028) ($MN)
Table 27 North America Specialty Generics Market Outlook, By Topical (2020-2028) ($MN)
Table 28 North America Specialty Generics Market Outlook, By Parenteral (2020-2028) ($MN)
Table 29 North America Specialty Generics Market Outlook, By Other Types (2020-2028) ($MN)
Table 30 North America Specialty Generics Market Outlook, By Application (2020-2028) ($MN)
Table 31 North America Specialty Generics Market Outlook, By Hepatitis C (2020-2028) ($MN)
Table 32 North America Specialty Generics Market Outlook, By Multiple Sclerosis (2020-2028) ($MN)
Table 33 North America Specialty Generics Market Outlook, By Inflammatory Conditions (2020-2028) ($MN)
Table 34 North America Specialty Generics Market Outlook, By Oncology (2020-2028) ($MN)
Table 35 North America Specialty Generics Market Outlook, By Cardiovascular (2020-2028) ($MN)
Table 36 North America Specialty Generics Market Outlook, By Infectious Diseases (2020-2028) ($MN)
Table 37 North America Specialty Generics Market Outlook, By Autoimmune Diseases (2020-2028) ($MN)
Table 38 North America Specialty Generics Market Outlook, By Other Applications (2020-2028) ($MN)
Table 39 North America Specialty Generics Market Outlook, By End User (2020-2028) ($MN)
Table 40 North America Specialty Generics Market Outlook, By Hospital Pharmacy (2020-2028) ($MN)
Table 41 North America Specialty Generics Market Outlook, By Retail Pharmacy (2020-2028) ($MN)
Table 42 North America Specialty Generics Market Outlook, By Specialty Pharmacy (2020-2028) ($MN)
Table 43 North America Specialty Generics Market Outlook, By Online Pharmacies (2020-2028) ($MN)
Table 44 North America Specialty Generics Market Outlook, By Other End Users (2020-2028) ($MN)
Table 45 Europe Specialty Generics Market Outlook, By Country (2020-2028) ($MN)
Table 46 Europe Specialty Generics Market Outlook, By Type (2020-2028) ($MN)
Table 47 Europe Specialty Generics Market Outlook, By Oral Drugs (2020-2028) ($MN)
Table 48 Europe Specialty Generics Market Outlook, By Injectables (2020-2028) ($MN)
Table 49 Europe Specialty Generics Market Outlook, By Topical (2020-2028) ($MN)
Table 50 Europe Specialty Generics Market Outlook, By Parenteral (2020-2028) ($MN)
Table 51 Europe Specialty Generics Market Outlook, By Other Types (2020-2028) ($MN)
Table 52 Europe Specialty Generics Market Outlook, By Application (2020-2028) ($MN)
Table 53 Europe Specialty Generics Market Outlook, By Hepatitis C (2020-2028) ($MN)
Table 54 Europe Specialty Generics Market Outlook, By Multiple Sclerosis (2020-2028) ($MN)
Table 55 Europe Specialty Generics Market Outlook, By Inflammatory Conditions (2020-2028) ($MN)
Table 56 Europe Specialty Generics Market Outlook, By Oncology (2020-2028) ($MN)
Table 57 Europe Specialty Generics Market Outlook, By Cardiovascular (2020-2028) ($MN)
Table 58 Europe Specialty Generics Market Outlook, By Infectious Diseases (2020-2028) ($MN)
Table 59 Europe Specialty Generics Market Outlook, By Autoimmune Diseases (2020-2028) ($MN)
Table 60 Europe Specialty Generics Market Outlook, By Other Applications (2020-2028) ($MN)
Table 61 Europe Specialty Generics Market Outlook, By End User (2020-2028) ($MN)
Table 62 Europe Specialty Generics Market Outlook, By Hospital Pharmacy (2020-2028) ($MN)
Table 63 Europe Specialty Generics Market Outlook, By Retail Pharmacy (2020-2028) ($MN)
Table 64 Europe Specialty Generics Market Outlook, By Specialty Pharmacy (2020-2028) ($MN)
Table 65 Europe Specialty Generics Market Outlook, By Online Pharmacies (2020-2028) ($MN)
Table 66 Europe Specialty Generics Market Outlook, By Other End Users (2020-2028) ($MN)
Table 67 Asia Pacific Specialty Generics Market Outlook, By Country (2020-2028) ($MN)
Table 68 Asia Pacific Specialty Generics Market Outlook, By Type (2020-2028) ($MN)
Table 69 Asia Pacific Specialty Generics Market Outlook, By Oral Drugs (2020-2028) ($MN)
Table 70 Asia Pacific Specialty Generics Market Outlook, By Injectables (2020-2028) ($MN)
Table 71 Asia Pacific Specialty Generics Market Outlook, By Topical (2020-2028) ($MN)
Table 72 Asia Pacific Specialty Generics Market Outlook, By Parenteral (2020-2028) ($MN)
Table 73 Asia Pacific Specialty Generics Market Outlook, By Other Types (2020-2028) ($MN)
Table 74 Asia Pacific Specialty Generics Market Outlook, By Application (2020-2028) ($MN)
Table 75 Asia Pacific Specialty Generics Market Outlook, By Hepatitis C (2020-2028) ($MN)
Table 76 Asia Pacific Specialty Generics Market Outlook, By Multiple Sclerosis (2020-2028) ($MN)
Table 77 Asia Pacific Specialty Generics Market Outlook, By Inflammatory Conditions (2020-2028) ($MN)
Table 78 Asia Pacific Specialty Generics Market Outlook, By Oncology (2020-2028) ($MN)
Table 79 Asia Pacific Specialty Generics Market Outlook, By Cardiovascular (2020-2028) ($MN)
Table 80 Asia Pacific Specialty Generics Market Outlook, By Infectious Diseases (2020-2028) ($MN)
Table 81 Asia Pacific Specialty Generics Market Outlook, By Autoimmune Diseases (2020-2028) ($MN)
Table 82 Asia Pacific Specialty Generics Market Outlook, By Other Applications (2020-2028) ($MN)
Table 83 Asia Pacific Specialty Generics Market Outlook, By End User (2020-2028) ($MN)
Table 84 Asia Pacific Specialty Generics Market Outlook, By Hospital Pharmacy (2020-2028) ($MN)
Table 85 Asia Pacific Specialty Generics Market Outlook, By Retail Pharmacy (2020-2028) ($MN)
Table 86 Asia Pacific Specialty Generics Market Outlook, By Specialty Pharmacy (2020-2028) ($MN)
Table 87 Asia Pacific Specialty Generics Market Outlook, By Online Pharmacies (2020-2028) ($MN)
Table 88 Asia Pacific Specialty Generics Market Outlook, By Other End Users (2020-2028) ($MN)
Table 89 South America Specialty Generics Market Outlook, By Country (2020-2028) ($MN)
Table 90 South America Specialty Generics Market Outlook, By Type (2020-2028) ($MN)
Table 91 South America Specialty Generics Market Outlook, By Oral Drugs (2020-2028) ($MN)
Table 92 South America Specialty Generics Market Outlook, By Injectables (2020-2028) ($MN)
Table 93 South America Specialty Generics Market Outlook, By Topical (2020-2028) ($MN)
Table 94 South America Specialty Generics Market Outlook, By Parenteral (2020-2028) ($MN)
Table 95 South America Specialty Generics Market Outlook, By Other Types (2020-2028) ($MN)
Table 96 South America Specialty Generics Market Outlook, By Application (2020-2028) ($MN)
Table 97 South America Specialty Generics Market Outlook, By Hepatitis C (2020-2028) ($MN)
Table 98 South America Specialty Generics Market Outlook, By Multiple Sclerosis (2020-2028) ($MN)
Table 99 South America Specialty Generics Market Outlook, By Inflammatory Conditions (2020-2028) ($MN)
Table 100 South America Specialty Generics Market Outlook, By Oncology (2020-2028) ($MN)
Table 101 South America Specialty Generics Market Outlook, By Cardiovascular (2020-2028) ($MN)
Table 102 South America Specialty Generics Market Outlook, By Infectious Diseases (2020-2028) ($MN)
Table 103 South America Specialty Generics Market Outlook, By Autoimmune Diseases (2020-2028) ($MN)
Table 104 South America Specialty Generics Market Outlook, By Other Applications (2020-2028) ($MN)
Table 105 South America Specialty Generics Market Outlook, By End User (2020-2028) ($MN)
Table 106 South America Specialty Generics Market Outlook, By Hospital Pharmacy (2020-2028) ($MN)
Table 107 South America Specialty Generics Market Outlook, By Retail Pharmacy (2020-2028) ($MN)
Table 108 South America Specialty Generics Market Outlook, By Specialty Pharmacy (2020-2028) ($MN)
Table 109 South America Specialty Generics Market Outlook, By Online Pharmacies (2020-2028) ($MN)
Table 110 South America Specialty Generics Market Outlook, By Other End Users (2020-2028) ($MN)
Table 111 Middle East & Africa Specialty Generics Market Outlook, By Country (2020-2028) ($MN)
Table 112 Middle East & Africa Specialty Generics Market Outlook, By Type (2020-2028) ($MN)
Table 113 Middle East & Africa Specialty Generics Market Outlook, By Oral Drugs (2020-2028) ($MN)
Table 114 Middle East & Africa Specialty Generics Market Outlook, By Injectables (2020-2028) ($MN)
Table 115 Middle East & Africa Specialty Generics Market Outlook, By Topical (2020-2028) ($MN)
Table 116 Middle East & Africa Specialty Generics Market Outlook, By Parenteral (2020-2028) ($MN)
Table 117 Middle East & Africa Specialty Generics Market Outlook, By Other Types (2020-2028) ($MN)
Table 118 Middle East & Africa Specialty Generics Market Outlook, By Application (2020-2028) ($MN)
Table 119 Middle East & Africa Specialty Generics Market Outlook, By Hepatitis C (2020-2028) ($MN)
Table 120 Middle East & Africa Specialty Generics Market Outlook, By Multiple Sclerosis (2020-2028) ($MN)
Table 121 Middle East & Africa Specialty Generics Market Outlook, By Inflammatory Conditions (2020-2028) ($MN)
Table 122 Middle East & Africa Specialty Generics Market Outlook, By Oncology (2020-2028) ($MN)
Table 123 Middle East & Africa Specialty Generics Market Outlook, By Cardiovascular (2020-2028) ($MN)
Table 124 Middle East & Africa Specialty Generics Market Outlook, By Infectious Diseases (2020-2028) ($MN)
Table 125 Middle East & Africa Specialty Generics Market Outlook, By Autoimmune Diseases (2020-2028) ($MN)
Table 126 Middle East & Africa Specialty Generics Market Outlook, By Other Applications (2020-2028) ($MN)
Table 127 Middle East & Africa Specialty Generics Market Outlook, By End User (2020-2028) ($MN)
Table 128 Middle East & Africa Specialty Generics Market Outlook, By Hospital Pharmacy (2020-2028) ($MN)
Table 129 Middle East & Africa Specialty Generics Market Outlook, By Retail Pharmacy (2020-2028) ($MN)
Table 130 Middle East & Africa Specialty Generics Market Outlook, By Specialty Pharmacy (2020-2028) ($MN)
Table 131 Middle East & Africa Specialty Generics Market Outlook, By Online Pharmacies (2020-2028) ($MN)
Table 132 Middle East & Africa Specialty Generics Market Outlook, By Other End Users (2020-2028) ($MN)

$4,150
$7,500

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings